ATE381957T1 - Verwendung eines antimykotischen echinocandin- mittels in kombination mit einem antibakteriellen glycopeptid-mittel - Google Patents

Verwendung eines antimykotischen echinocandin- mittels in kombination mit einem antibakteriellen glycopeptid-mittel

Info

Publication number: ATE381957T1
Authority: AT; Austria
Prior art keywords: agent; combination; echinocandin; antifungal; glycopeptide
Prior art date: 2003-07-22

Application number

AT04778676T

Other languages

English (en)

Inventor

Kone Kaniga

Original Assignee

Theravance Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-07-22

Filing date

2004-07-21

Publication date

2008-01-15

2004-07-21 Application filed by Theravance Inc filed Critical Theravance Inc

2008-01-15 Application granted granted Critical

2008-01-15 Publication of ATE381957T1 publication Critical patent/ATE381957T1/de

Links

DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 title abstract 4
108010049047 Echinocandins Proteins 0.000 title abstract 4
102000002068 Glycopeptides Human genes 0.000 title abstract 4
108010015899 Glycopeptides Proteins 0.000 title abstract 4
229940121375 antifungal agent Drugs 0.000 title abstract 4
230000000844 anti-bacterial effect Effects 0.000 title 1
230000000843 anti-fungal effect Effects 0.000 title 1
239000003242 anti bacterial agent Substances 0.000 abstract 3
239000003429 antifungal agent Substances 0.000 abstract 3
206010017533 Fungal infection Diseases 0.000 abstract 1
208000031888 Mycoses Diseases 0.000 abstract 1
125000004432 carbon atom Chemical group C* 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT04778676T 2003-07-22 2004-07-21 Verwendung eines antimykotischen echinocandin- mittels in kombination mit einem antibakteriellen glycopeptid-mittel ATE381957T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US48917303P	2003-07-22	2003-07-22

Publications (1)

Publication Number	Publication Date
ATE381957T1 true ATE381957T1 (de)	2008-01-15

Family

ID=34215831

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04778676T ATE381957T1 (de)	2003-07-22	2004-07-21	Verwendung eines antimykotischen echinocandin- mittels in kombination mit einem antibakteriellen glycopeptid-mittel

Country Status (7)

Country	Link
US (2)	US7452861B2 (de)
EP (1)	EP1654036B1 (de)
JP (2)	JP4664912B2 (de)
AT (1)	ATE381957T1 (de)
DE (1)	DE602004010915T2 (de)
ES (1)	ES2298821T3 (de)
WO (1)	WO2005018743A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE602004010915T2 (de) *	2003-07-22	2008-12-11	Theravance, Inc., South San Francisco	Verwendung eines antimykotischen echinocandin-mittels in kombination mit einem antibakteriellen glycopeptid-mittel
US8778874B2 (en)	2004-11-29	2014-07-15	National University Corporation Nagoya University	Glycopeptide antibiotic monomer derivatives
TW200808818A (en) *	2006-05-26	2008-02-16	Shionogi & Co	Glycopeptide antibiotic derivatives
CA2710602A1 (en) *	2007-12-26	2009-07-09	Lead Therapeutics, Inc.	Novel semi-synthetic glycopeptides as antibacterial agents
CN101959900A (zh) *	2007-12-26	2011-01-26	盐野义制药株式会社	糖肽类抗生素糖基化衍生物
US20110136729A1 (en) *	2009-05-26	2011-06-09	Shien Lu	Occidiofungin, a unique antifungal glycopeptide produced by a strain of burkholderia contaminans
CN102618606B (zh) *	2011-01-30	2014-09-10	浙江海正药业股份有限公司	一种棘白菌素生物转化方法
ES2645074T3 (es)	2011-03-03	2017-12-04	Cidara Therapeutics, Inc.	Agentes antifúngicos y sus usos
RU2639483C2 (ru)	2012-03-19	2017-12-21	Сидара Терапьютикс, Инк.	Режимы дозирования для соединений класса эхинокандинов
WO2014085419A1 (en)	2012-11-29	2014-06-05	The Texas A&M University System	Engineering the production of a conformational variant of occidiofungin that has enhanced inhibitory activity against fungal species
US9668970B2 (en) *	2013-12-02	2017-06-06	Intelgenx Corp.	Film dosage form with extended release mucoadhesive particles
US11033493B2 (en)	2013-12-02	2021-06-15	Intelgenx Corp.	Film dosage form with extended release mucoadhesive particles
US10272038B2 (en)	2013-12-02	2019-04-30	Intelgenx Corp.	Film dosage form with extended release mucoadhesive particles
US10265374B2 (en)	2014-09-12	2019-04-23	Mississippi State University	Occidiofungin formations and uses thereof
CN108883152A (zh)	2016-01-08	2018-11-23	奇达拉治疗公司	防止和治疗肺孢子虫感染的方法
CN108712909A (zh) *	2016-02-18	2018-10-26	梅琳塔治疗公司	奥利万星制剂
WO2017161016A1 (en)	2016-03-16	2017-09-21	Cidara Therapeutics, Inc.	Dosing regimens for treatment of fungal infections
US11197909B2 (en)	2017-07-12	2021-12-14	Cidara Therapeutics, Inc.	Compositions and methods for the treatment of fungal infections
CN112274046B (zh) *	2020-10-29	2022-07-22	温州欧迪家居用品有限公司	一种抑菌毛巾架及其制备工艺

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0596929B1 (de)	1991-07-29	1995-07-26	GRUPPO LEPETIT S.p.A.	Amidderivate vom Antibiotikum A 40926
US6743777B1 (en)	1992-03-19	2004-06-01	Eli Lilly And Company	Cyclic peptide antifungal agents and process for preparation thereof
US5378804A (en)	1993-03-16	1995-01-03	Merck & Co., Inc.	Aza cyclohexapeptide compounds
TW457248B (en)	1994-01-28	2001-10-01	Lilly Co Eli	Glycopeptide antibiotic derivatives
US5840684A (en) *	1994-01-28	1998-11-24	Eli Lilly And Company	Glycopeptide antibiotic derivatives
WO1996011210A1 (en)	1994-10-07	1996-04-18	Fujisawa Pharmaceutical Co., Ltd.	Cyclic hexapeptides having antibiotic activity
US5741782A (en) *	1996-03-29	1998-04-21	Cryolife, Inc.	Antibiotic cocktail and method of use
WO1998006265A2 (en)	1996-08-09	1998-02-19	Buckman Laboratories International, Inc.	Treatment of fungal infections using a combination of an anti-fungal compound and an n-alkyl-heterocyclic compound, especially n-dodecyl-morpholine
CA2301746C (en) *	1997-08-26	2011-02-15	Board Of Regents, The University Of Texas System	Chelators in combination with biocides: treatment of microbially induced biofilm and corrosion
AUPQ066399A0 (en)	1999-05-31	1999-06-24	Fujisawa Pharmaceutical Co., Ltd.	Antifungal combination use
AUPQ462399A0 (en)	1999-12-13	2000-01-13	Fujisawa Pharmaceutical Co., Ltd.	New use
WO2001095876A1 (en) *	2000-06-09	2001-12-20	Baylor College Of Medicine	The combination of antimicrobial agents and bacterial interference to coat medical devices
UA75083C2 (uk)	2000-06-22	2006-03-15	Тераванс, Інк.	Похідні глікопептидфосфонатів
US20040024505A1 (en) *	2002-08-05	2004-02-05	Salib Albert Chenouda	System and method for operating a rollover control system in a transition to a rollover condition
JP2006528704A (ja)	2003-05-27	2006-12-21	セラヴァンスインコーポレーテッド	グリコペプチド抗細菌剤と組み合わせたポリエンマクロライド抗真菌剤の使用
DE602004010915T2 (de) *	2003-07-22	2008-12-11	Theravance, Inc., South San Francisco	Verwendung eines antimykotischen echinocandin-mittels in kombination mit einem antibakteriellen glycopeptid-mittel

2004
- 2004-07-21 DE DE602004010915T patent/DE602004010915T2/de not_active Expired - Lifetime
- 2004-07-21 AT AT04778676T patent/ATE381957T1/de not_active IP Right Cessation
- 2004-07-21 JP JP2006521182A patent/JP4664912B2/ja not_active Expired - Fee Related
- 2004-07-21 US US10/895,492 patent/US7452861B2/en not_active Expired - Lifetime
- 2004-07-21 EP EP04778676A patent/EP1654036B1/de not_active Expired - Lifetime
- 2004-07-21 WO PCT/US2004/023289 patent/WO2005018743A1/en not_active Ceased
- 2004-07-21 ES ES04778676T patent/ES2298821T3/es not_active Expired - Lifetime
2008
- 2008-10-01 US US12/243,076 patent/US7902148B2/en not_active Expired - Fee Related
2010
- 2010-10-07 JP JP2010227982A patent/JP2011001390A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
US20050026819A1 (en)	2005-02-03
JP4664912B2 (ja)	2011-04-06
US7902148B2 (en)	2011-03-08
DE602004010915T2 (de)	2008-12-11
US20090221470A1 (en)	2009-09-03
ES2298821T3 (es)	2008-05-16
US7452861B2 (en)	2008-11-18
JP2006528188A (ja)	2006-12-14
JP2011001390A (ja)	2011-01-06
WO2005018743A1 (en)	2005-03-03
EP1654036A1 (de)	2006-05-10
EP1654036B1 (de)	2007-12-26
DE602004010915D1 (de)	2008-02-07

Legal Events

Date	Code	Title	Description
2008-06-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE381957T1 (de)	2008-01-15	Verwendung eines antimykotischen echinocandin- mittels in kombination mit einem antibakteriellen glycopeptid-mittel
EP1482791A4 (de)	2007-04-04	Antimikrobielle therapeutische zusammensetzungen und ihre verwendung
CO5700767A2 (es)	2006-11-30	Procedimiento de tratamiento de rechazo de transplantes
TR201900306T4 (tr)	2019-02-21	Mek inhibitörlerini kullanma yöntemleri.
BR9917080A (pt)	2002-03-12	Composto, composição farmacêutica, uso do composto e método de tratamento ou prevenção de uma disfunção tromboembólica
TNSN06071A1 (en)	2007-10-03	Use of modified cyclosporins for the treatment of hcv disorders
WO2004089396A3 (en)	2005-01-06	Anti-fungal peptidomimetics
DE60113851D1 (de)	2006-02-16	Bakteriophage mit breitem wirtspektrum
EA200802166A1 (ru)	2009-06-30	Стабильная фармацевтическая композиция с защитным действием от раздражения (варианты), способ ее получения и способ лечения кальций-миметиком с ее помощью
BR0316203A (pt)	2005-10-04	Uso de um agente antialérgico e um esteróide para tratar rinite alérgica
PL1789419T3 (pl)	2009-11-30	Inhibitory gyrazy i ich zastosowanie
TNSN07240A1 (en)	2008-11-21	Compounds for flaviviridae treatment
WO2006129085A3 (en)	2007-02-01	High affinity melan-a t cell receptors
SG160436A1 (en)	2010-04-29	Polymer interlayers comprising skin layers
WO2005062882A3 (en)	2005-12-29	Rifamycin analogs and uses thereof
DE69735545D1 (de)	2006-05-11	Verwendung von beta-blatt mimetika als protease und kinase hemmer und alshemmer eines transkriptionsfaktors
CY1108540T1 (el)	2013-09-04	Ταυτοποιηση θεραπευτικων ενωσεων
WO2008079270A3 (en)	2008-10-16	Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
MX372951B (es)	2020-04-02	Composiciones y metodos de tratamiento que comprenden ceftarolina.
WO2008143705A3 (en)	2009-01-22	Methods and compositions for rapid inactivation of proteins
MY147790A (en)	2013-01-31	Stable emulsion composition
BR0307085A (pt)	2004-12-07	Terapia combinada para o tratamento de infecções bacterianas
ES2192764T3 (es)	2003-10-16	Mimeticos de lamina beta y metodos relacionados con el uso de los mismos.
BRPI0508084A (pt)	2007-07-17	método para o tratamento de um distúrbio neurológico, e, uso de meridamicina ou um sal do mesmo
BRPI0520129A2 (pt)	2009-04-28	uso de 5'-metiltioadenosina (mta) na prevenÇço e/ou no tratamento de doenÇas auto-imunes e/ou rejeiÇço de transplante